J&J

Showing 15 posts of 227 posts found.

Risperdal image

J&J fined after ‘lying to patients for profit’

April 16, 2012
Medical Communications, Sales and Marketing J&J, JJ, Janssen, Risperdal, US

A US judge has slapped a $1.19 billion fine on Johnson & Johnson after it was found to be downplaying …

J&J unveils plans to boost Doxil supplies

April 10, 2012
Manufacturing and Production Ben Venue, Doxil, J&J, JJ, drug shortages

Johnson & Johnson is planning to transfer filling and packaging of Doxil to another supplier in an attempt to alleviate …

Synthes plant cited in FDA warning letter

March 8, 2012
Manufacturing and Production FDA, J&J, JJ, Synthes, manufacturing

The US FDA has sent a warning letter to surgical equipment manufacturer Synthes upbraiding it for deficiencies at a manufacturing …

Alex Gorsky named new chief executive of J&J

February 22, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Janssen, Weldon

Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated …

Risperdal image

J&J to pay $1 billion for Risperdal charges

January 9, 2012
Sales and Marketing J&J, JJ, Janssen, Risperdal

Johnson & Johnson will pay more than $1 billion in the US to resolve a civil investigation into the marketing …

Janssen sets up new mental health social networking site

November 28, 2011
Medical Communications J&J, JJ, Janssen, NHS

Janssen and the NHS Confederation have established a new mental health social networking site. The service, which will be free …

Doxil shortages exacerbated as Ben Venue shutters plant

November 22, 2011
Manufacturing and Production Doxil, J&J, JJ, manufacturing and production

An acute shortage of Johnson & Johnson’s cancer drug Doxil (doxorubicin) in the US could get worse following a decision …

Xarelto succeeds in new study

November 14, 2011
Sales and Marketing Bayer, FDA, J&J, JJ, Xarelto

In a new study J&J and Bayer’s blood thinner Xarelto reduced deaths in patients after a heart attack, which could …

Merck & Co

Merck pulls out of J&J consumer venture

September 29, 2011
Sales and Marketing J&J, JJ, Merc & Co, OTC

Merck & Co has exited a joint venture with J&J, selling its stake in the J&J/Merck Consumer Pharmaceuticals business to …

Tylenol recall

J&J’s latest recall put down to new factor

August 19, 2011
Manufacturing and Production J&J, JJ, Tylenol, recalls

Yet another Johnson & Johnson recall has been announced, but this time the perpetrator doesn’t feature among the ‘usual suspects’. …

Triple regimen HIV pill gains approval

August 11, 2011
Gilead, HIV, J&J, JJ, Truvada

A new three-in-one pill Complera has been approved in the US as a first line treatment for HIV. Complera combines …

J&J aims for Japanese pharma expansion

May 27, 2011
Research and Development, Sales and Marketing J&J, JJ

Johnson & Johnson has identified Japan as a key growth market for its pharma business as it outlines its strategic …

Johnson & Johnson's Tylenol

J&J reorganises McNeil as recalls keep coming

April 5, 2011
Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, TBA, TCA, Tylenol, manufacturing compliance, pharma manufacturing, recalls, tribromoanisole, trichloroanisole

Johnson & Johnson has announced a major reworking of its troubled McNeil Consumer Healthcare unit, just as quality problems force …

J&J charged with US manufacturing violations

March 15, 2011
Manufacturing and Production J&J, JJ, Johnson and Johnson, McNeil Consumer Healthcare, McNeil Fort Washington, McNeil recall, Motrin recall, manufacturing compliance, pharma manufacturing, recalls

Johnson & Johnson subsidiary McNeil Consumer Healthcare has been officially charged with manufacturing and distributing drugs in violation of federal …

J&J hepatitis C drug begins phase III trials

February 23, 2011
Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C

Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …

The Gateway to Local Adoption Series

Latest content